Do neurooncological patients and their significant others agree on quality of life ratings?

Health and Quality of Life Outcomes

Volumn 7, Issue , 2009, Pages

  Giesinger, Johannes M ^a   Golser, Miriam ^a   Erharter, Astrid ^a   Kemmler, Georg ^a   Schauer Maurer, Gabriele ^a   Stockhammer, Guenter ^a   Muigg, Armin ^a   Hutterer, Markus ^a   Rumpold, Gerhard ^a   Holzner, Bernhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANOREXIA; ARTICLE; BRAIN TUMOR; COGNITION; COMMUNICATION DISORDER; CONSTIPATION; CONTROLLED STUDY; DYSPNEA; EMOTION; FATIGUE; FEMALE; HAIR LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NEUROONCOLOGY; ONCOLOGY; PAIN; PHYSICAL CAPACITY; PRURITUS; QUALITY OF LIFE INDEX; QUALITY OF LIFE SELF AND PROXY RATINGS; SEIZURE; SLEEP DISORDER; SOCIAL STATUS; SPOUSE; TASTE DISORDER; VISUAL DISORDER; COST OF ILLNESS; CUSTODY; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; SOCIOECONOMICS; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; COST OF ILLNESS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROXY; QUALITY OF LIFE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS;

EID: 71149111714     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-7-87     Document Type: Article

References (23)

1. Velikova G, Booth L, Smith AB, Brown PM, Lynch P, Brown JM, Selby PJ. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol 2004, 22(4):714-24. 10.1200/JCO.2004.06.078, 14966096.
2. Taenzer P, Bultz BD, Carlson LE, Speca M, DeGagne T, Olson K, Doll R, Rosberger Z. Impact of computerized quality of life screening on physician behaviour and patient satisfaction in lung cancer outpatients. Psychooncology 2000, 9(3):203-13. 10.1002/1099-1611(200005/06)9:3<203::AID-PON453>3.3.CO;2-P, 10871716.
3. MacDonald D, Kiebert G, Padros M, Yung A, Olson J. Benefit of temozolamide compared to procarbazine treatment of glioblastoma multiforme at first relapse: effect on neurological functioning, performance status, and health related quality of life. Cancer Invest 2005, 23(2):138-144. 10.1081/CNV-200050453, 15813507.
4. Prados M, Schold S, Fine H, Jaeckle K, Hochberg F, Mechtler L, Fetell M, Phuphanich S, Feun L, Janus T, Ford K, Graney W. A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma. Neuro-Oncol 2003, 5(2):96-103. 10.1215/15228517-5-2-96, 1920676, 12672281.
5. Hart M, Grant R, Garside R, Rogers G, Somerville M, Stein K. Temozolomide for high grade glioma. Cochrane Database Syst Rev 2008, 4:CD007415.
6. Sneeuw KC, Aaronson NK, Osoba D, Muller MJ, Hsu MA, Yung WK, Brada M, Newlands ES. The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care 1997, 35(5):490-506. 10.1097/00005650-199705000-00006, 9140337.
7. Sneeuw KC, Aaronson NK, Sprangers MA, Detmar SB, Wever LD, Schornagel JH. Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J Clin Epidemiol 1998, 51(7):617-31. 10.1016/S0895-4356(98)00040-7, 9674669.
8. Bakitas M, Ahles T, Skalla K, Brokaw F, Byock I, Hanscom B, Lyons K, Hegel M. Proxy perspectives regarding end-of-life care for persons with cancer. Cancer 2008, 112(8):1854-61. 10.1002/cncr.23381, 18306393.
9. Milne DJ, Mulder LL, Beelen HCM, Schofield P, Kempen GIJM, Aranda S. Patients' self-report and family caregivers' perception of quality of life in patients with advanced cancer: how do they compare?. Eur J Cancer Care (Engl) 2006, 15(2):125-32. 10.1111/j.1365-2354.2005.00639.x, 16643259.
10. Wilson KA, Dowling AJ, Abdolell M, Tannock IF. Perception of quality of life by patients, partners and treating physicians. Qual Life Res 2000, 9(9):1041-52. 10.1023/A:1016647407161, 11332225.
11. Pearcy R, Waldron D, O'Boyle C, MacDonagh R. Proxy assessment of quality of life in patients with prostate cancer: how accurate are partners and urologists?. Journal of the Royal Society of Medicine 2008, 101(3):133-138. 10.1258/jrsm.2008.081002, 2270239, 18344470.
12. Dawson N, Singer M, Lenert L, Patterson M, Sami S, Gonsenhouser I, Lindstrom H, Smyth K, Barber M, Whitehouse P. Health state valuation in mild to moderate cognitive impairment: feasibility of computer-based, direct patient utility assessment. Medical Decision Making 2008, 28(2):220-232. 10.1177/0272989X07311750, 18349434.
13. Varni J, Limbers C, Burwinkle T. Parent proxy-report of their children's health-related quality of life: an analysis of 13,878 parents' reliability and validity across age subgroups using the PedsQLTM 4.0 Generic Core Scales. Health and Quality of Life Outcomes 2007, 5(1):2. 10.1186/1477-7525-5-2, 1769359, 17201923.
14. Holzner B, Zabernigg A, Kemmler G, Baier S, Kopp M, Sperner Unterweger B. Computerized assessment of quality of life in patients undergoing chemotherapy. Qual Life Res 2004, 13(9):1523.
15. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85(5):365-76. 10.1093/jnci/85.5.365, 8433390.
16. Osoba D, Aaronson NK, Muller M, Sneeuw K, Hsu MA, Yung WK, Brada M, Newlands E. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 1996, 5(1):139-50. 10.1007/BF00435979, 8901377.
17. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998, 16(1):139-44.
18. King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996, 5(6):555-67. 10.1007/BF00439229, 8993101.
19. Bland J, Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 8476:307-310.
20. Erharter A, Giesinger J, Kemmler G, Schauer-Maurer G, Stockhammer G, Muigg A, Rumpold G, Sperner-Unterweger B, Holzner B. Implementation of computer-based quality of life monitoring in brain tumor outpatients in routine clinical practice. J Pain and Symptom Management
21. Brown P, Decker P, Rummans T, Clark M, Frost M, Ballman K, Arusell R, Buckner J. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of life. Am J Clin Oncol 2008, 31(2):163-168. 10.1097/COC.0b013e318149f1d3, 18391601.
22. Weitzner M, Meyers C, Gelke C, Byrne K, Cella D, Levin V. The functional assessment of cancer therapy (FACT) scale: Development of a brain subscale and the revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 1995, 75:1151-1161. 10.1002/1097-0142(19950301)75:5<1151::AID-CNCR2820750515>3.0.CO;2-Q, 7850714.
23. Gundy C, Aaronson N. The influence of proxy perspective on patient-proxy agreement in the evaluation of health-related quality of life: an empirical study. Medical Care 2008, 46(2):209-216. 10.1097/MLR.0b013e318158af13, 18219250.